herbal extract PG201

04/02/2016 - "PG201 can be suggested as an effective treatment of knee osteoarthritis. "
10/01/2014 - "The objectives of the study are to demonstrate the non-inferiority of PG201 (Layla(®)) 600 mg in comparison with celecoxib 200 mg for the treatment of symptomatic knee osteoarthritis (OA). "
10/01/2014 - "Efficacy and safety of PG201 (Layla(®)) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study."
04/02/2016 - "To compare the efficacy and safety of PG201 and SKI306X in patients with knee osteoarthritis. "
04/02/2016 - "This prospective, randomized, double-blinded, double-dummy, multicenter study compared the efficacy and safety of PG201 (Layla®), a new product from extracts of 12 plant sources and SKI306X (Joins®) which have been well investigated and in relatively wide usage among herbal medicine, for the treatment of patients with knee osteoarthritis. "

04/02/2016 - "The results of this study showed that PG201 significantly reduced knee pain and improved knee function and were comparable to SKI306X. "
10/01/2014 - "At weeks 8, the 100-mm pain VAS scores were significantly decreased in patients receiving both PG201 600 mg (p < 0.0001) and celecoxib 200 mg (p < 0.0001) as compared to the baseline scores; however, no statistically significant differences in these values were noted between the groups (p = 0.312). "

04/01/2018 - "PG201 is a botanical formulation, approved as an ethical drug (ETC) phytomedicine for treatment of patients with osteoarthritis in Korea, following satisfactory phase II and phase III studies. "
06/17/2005 - "PG201 indeed has great potential as a form of treatment for osteoarthritis."
04/02/2016 - "Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis."
06/17/2005 - "In order to assess the therapeutic effects of PG201 (an ethanol extract from herbs) on osteoarthritis, we investigated whether PG201 could suppress the disease progression of collagenase-induced arthritis (CNIA) in rabbits. "

04/01/2018 - "In this study, the possibility of using PG201 to treat multiple sclerosis was explored. "
04/01/2018 - "These findings indicate that PG201 may exert strong immunomodulatory effects in the EAE model via suppression of T cell activation, and that PG201 is a therapeutic reagent for the treatment of multiple sclerosis."

05/01/2003 - "The present study was done in order to assess the therapeutic effects of PG201 in collagen-induced arthritis (CIA) in mice. "
05/01/2003 - "Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice."